First Trust Health Care AlphaDEX Fund (FXH) Holdings
FXH holdings summary
as of Oct 25, 2026- Holdings
- 71 positions listed
- Top 10 weight
- 24.6% of net assets
- Effective holdings
- 57 equal-weight equivalent
- Largest holding
- CNC 2.71% Centene Corporation
- Annual turnover
- 0.0% of the portfolio traded
All FXH holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | CNC | Centene Corporation | Healthcare | 2.71% | $31.0M | $34.16B | — |
| 2 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 2.60% | $29.7M | $13.83B | 35.6 |
| 3 | CI | Cigna Corporation | Healthcare | 2.58% | $29.4M | $79.88B | 12.5 |
| 4 | GMED | Globus Medical, Inc. | Healthcare | 2.56% | $29.3M | $10.30B | 19.7 |
| 5 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 2.49% | $28.5M | $18.12B | 23.1 |
| 6 | MEDP | Medpace Holdings, Inc. | Healthcare | 2.48% | $28.3M | $17.26B | 36.3 |
| 7 | UHS | Universal Health Services, Inc. | Healthcare | 2.38% | $27.2M | $10.91B | 7.6 |
| 8 | CAI | Caris Life Sciences, Inc. | Healthcare | 2.35% | $26.8M | $8.64B | 18.1 |
| 9 | NTRA | Natera, Inc. | Healthcare | 2.22% | $25.3M | $56.71B | — |
| 10 | SOLV | Solventum Corporation | Healthcare | 2.19% | $25.1M | $14.61B | 10.5 |
| 11 | DXCM | DexCom, Inc. | Healthcare | 2.16% | $24.7M | $32.47B | 34.1 |
| 12 | ZTS | Zoetis Inc. | Healthcare | 2.15% | $24.5M | $32.80B | 13.1 |
| 13 | LLY | Eli Lilly and Company | Healthcare | 2.12% | $24.2M | $1.12T | 42.2 |
| 14 | CORT | Corcept Therapeutics Incorporated | Healthcare | 2.06% | $23.6M | $11.91B | 244.8 |
| 15 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 2.04% | $23.3M | $81.41B | 19.6 |
| 16 | EXEL | Exelixis, Inc. | Healthcare | 2.03% | $23.2M | $15.42B | 19.6 |
| 17 | GH | Guardant Health, Inc. | Healthcare | 2.03% | $23.2M | $21.28B | — |
| 18 | UTHR | United Therapeutics Corporation | Healthcare | 2.03% | $23.2M | $22.87B | 19.1 |
| 19 | THC | Tenet Healthcare Corporation | Healthcare | 2.02% | $23.1M | $21.52B | 10.5 |
| 20 | MDT | Medtronic plc | Healthcare | 1.97% | $22.5M | $121.20B | 23.3 |
| 21 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 1.96% | $22.4M | $31.42B | 16.0 |
| 22 | COO | The Cooper Companies, Inc. | Healthcare | 1.93% | $22.0M | $11.02B | 19.9 |
| 23 | BSX | Boston Scientific Corporation | Healthcare | 1.91% | $21.8M | $64.33B | 18.0 |
| 24 | AMGN | Amgen Inc. | Healthcare | 1.91% | $21.8M | $233.82B | 26.9 |
| 25 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.88% | $21.5M | $122.05B | 13.2 |
| 26 | TEM | Tempus AI, Inc. | Healthcare | 1.77% | $20.2M | $11.68B | — |
| 27 | INCY | Incyte Corporation | Healthcare | 1.72% | $19.6M | $22.92B | 14.4 |
| 28 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 1.66% | $19.0M | $13.65B | 14.4 |
| 29 | ELV | Elevance Health Inc. | Healthcare | 1.52% | $17.4M | $92.88B | 19.0 |
| 30 | QGEN | Qiagen N.V. | Healthcare | 1.47% | $16.8M | $9.53B | 23.4 |
| 31 | RMD | ResMed Inc. | Healthcare | 1.46% | $16.7M | $33.61B | 22.9 |
| 32 | LH | Laboratory Corporation of America Holdings | Healthcare | 1.42% | $16.3M | $25.79B | 26.3 |
| 33 | HCA | HCA Healthcare, Inc. | Healthcare | 1.40% | $16.0M | $99.34B | 15.4 |
| 34 | ASND | Ascendis Pharma A/S | Healthcare | 1.37% | $15.7M | $14.82B | 17.3 |
| 35 | VTRS | Viatris Inc. | Healthcare | 1.36% | $15.6M | $21.43B | — |
| 36 | ALGN | Align Technology, Inc. | Healthcare | 1.36% | $15.5M | $10.46B | 25.6 |
| 37 | STE | STERIS plc | Healthcare | 1.35% | $15.4M | $21.71B | 27.2 |
| 38 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 1.33% | $15.2M | $13.79B | 19.9 |
| 39 | ABBV | AbbVie Inc. | Healthcare | 1.32% | $15.1M | $504.37B | 80.6 |
| 40 | EHC | Encompass Health Corporation | Healthcare | 1.32% | $15.1M | $12.61B | 21.4 |
| 41 | DVA | DaVita Inc. | Healthcare | 1.31% | $15.0M | $11.95B | 15.8 |
| 42 | DGX | Quest Diagnostics Incorporated | Healthcare | 1.31% | $15.0M | $25.94B | 24.6 |
| 43 | RVMD | Revolution Medicines, Inc. | Healthcare | 1.13% | $12.9M | $38.14B | — |
| 44 | DOCS | Doximity, Inc. | Healthcare | 1.10% | $12.6M | $5.52B | 36.4 |
| 45 | BDX | Becton, Dickinson and Company | Healthcare | 1.00% | $11.4M | $52.23B | 44.6 |
| 46 | BIIB | Biogen Inc. | Healthcare | 0.99% | $11.3M | $34.37B | 41.3 |
| 47 | PFE | Pfizer Inc. | Healthcare | 0.98% | $11.1M | $168.60B | 38.9 |
| 48 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 0.96% | $11.0M | $12.98B | — |
| 49 | ENSG | The Ensign Group, Inc. | Healthcare | 0.96% | $11.0M | $10.29B | 27.7 |
| 50 | CHE | Chemed Corporation | Healthcare | 0.94% | $10.7M | $6.70B | 25.8 |
| 51 | NVST | Envista Holdings Corporation | Healthcare | 0.92% | $10.5M | $3.68B | 39.5 |
| 52 | HSIC | Henry Schein, Inc. | Healthcare | 0.92% | $10.5M | $9.63B | 25.2 |
| 53 | ABT | Abbott Laboratories | Healthcare | 0.92% | $10.5M | $181.50B | 33.8 |
| 54 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 0.90% | $10.3M | $126.66B | 28.9 |
| 55 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 0.82% | $9.4M | $7.90B | — |
| 56 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.81% | $9.2M | $8.23B | — |
| 57 | MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | 0.79% | $9.0M | $10.39B | — |
| 58 | UNH | UnitedHealth Group Incorporated | Healthcare | 0.51% | $5.8M | $360.32B | 25.8 |
| 59 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.48% | $5.5M | $44.20B | 39.8 |
| 60 | ISRG | Intuitive Surgical, Inc. | Healthcare | 0.48% | $5.5M | $150.74B | 48.9 |
| 61 | VEEV | Veeva Systems Inc. | Healthcare | 0.48% | $5.5M | $50.25B | 50.9 |
| 62 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.46% | $5.3M | $27.03B | 49.4 |
| 63 | HUM | Humana Inc. | Healthcare | 0.46% | $5.2M | $49.61B | 39.1 |
| 64 | SYK | Stryker Corporation | Healthcare | 0.45% | $5.1M | $113.02B | 30.5 |
| 65 | DHR | Danaher Corporation | Healthcare | 0.45% | $5.1M | $161.01B | 40.8 |
| 66 | ELAN | Elanco Animal Health Incorporated | Healthcare | 0.44% | $5.0M | $11.76B | — |
| 67 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 0.43% | $4.9M | $255.13B | 37.1 |
| 68 | JNJ | Johnson & Johnson | Healthcare | 0.43% | $4.9M | $615.87B | 38.8 |
| 69 | A | Agilent Technologies, Inc. | Healthcare | 0.43% | $4.9M | $48.77B | 34.1 |
| 70 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | 0.40% | $4.5M | $9.46B | 44.8 |
| 71 | INSM | Insmed Incorporated | Healthcare | 0.37% | $4.2M | $21.02B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($1.14B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
FXH sector breakdown
Sum of the weights of the holdings in each sector.
FXH top industries
FXH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF | 7.1% | 43 of 502 | 0.09% |
| VTI | Vanguard Total Stock Market ETF | 6.8% | 69 of 2,941 | 0.03% |
| QQQ | Invesco QQQ ETF | 3.0% | 7 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 2.8% | 3 of 30 | 0.16% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 5 of 8,035 | 0.05% |
| IWM | iShares Russell 2000 ETF | 0.0% | 0 of 1,962 | 0.19% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the FXH portfolio
First Trust Health Care AlphaDEX Fund holds 71 positions. The ten largest make up 24.6% of the fund and the top 50 87.3%, so it behaves like a portfolio of about 57 equally weighted stocks. The biggest positions are Centene Corporation (2.71%), Halozyme Therapeutics, Inc. (2.60%), Cigna Corporation (2.58%), Globus Medical, Inc. (2.56%), Zimmer Biomet Holdings, Inc. (2.49%).
By sector, Healthcare is 99.6%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: FXH chart, FXH performance, FXH dividends, FXH valuation, FXH overview.
FXH holdings FAQ
How many holdings does FXH have?
FXH holds 71 positions as of October 25, 2026.
What are the top 10 holdings of FXH?
The ten largest holdings are Centene Corporation (2.71%), Halozyme Therapeutics, Inc. (2.60%), Cigna Corporation (2.58%), Globus Medical, Inc. (2.56%), Zimmer Biomet Holdings, Inc. (2.49%), Medpace Holdings, Inc. (2.48%), Universal Health Services, Inc. (2.38%), Caris Life Sciences, Inc. (2.35%), Natera, Inc. (2.22%), Solventum Corporation (2.19%). Together they are 24.6% of the fund.
What percentage of FXH is Centene Corporation?
Centene Corporation is the largest holding at 2.71% of net assets, about $31.0M of the fund's $1.14B.
How concentrated is FXH?
The top 10 holdings are 24.6% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) FXH behaves like a portfolio of about 57 equally weighted stocks.